Skip to main content
Erschienen in: Endocrine Pathology 4/2018

28.08.2018

Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma

verfasst von: Sachiko Konosu-Fukaya, Kei Omata, Yuta Tezuka, Yoshikiyo Ono, Yayoi Aoyama, Fumitoshi Satoh, Fumiyoshi Fujishima, Hironobu Sasano, Yasuhiro Nakamura

Erschienen in: Endocrine Pathology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

In chromaffin cells, tyrosine hydroxylase (TH), aromatic l-amino acid decarboxylase (AADC), dopamine β-hydroxylase (DBH), and phenylethanolamine N-methyltransferase (PNMT) are mainly involved in catecholamine synthesis. In this study, we evaluated the association between the status of catecholamine-synthesizing enzymes and histopathological features of pheochromocytoma and extraadrenal paraganglioma with special emphasis upon their postoperative clinical behavior. Immunohistochemical evaluation of TH, DBH, AADC, PNMT, Ki 67, and S-100 was performed in 29 pheochromocytoma and 10 extraadrenal paraganglioma and one lymph node harboring metastatic pheochromocytoma. Among these cases, metastasis was subsequently developed in three cases. Urinary normetanephrine (U-NM) levels were significantly higher in clinical metastatic cases than non-metastatic ones. Ki 67 labeling index was significantly higher in both clinical metastatic cases and the Adrenal Gland Scaled Score (PASS) score of ≧ 4 cases than PASS < 4 cases, although this score was originally used in pheochromocytoma. H-score of AADC and DBH were significantly lower in PASS ≧ 4 cases than those with < 4 cases, and in the cases associated with intratumoral necrosis (n = 4), the presence of spindle shaped tumor cells (n = 4), and large nests of cells or diffuse growth (n = 5). Lower status of intratumoral AADC could be related to poor differentiation of tumor cells in both catecholamine production and morphology and could be related to aggressive biological behavior of both pheochromocytoma and extraadrenal paraganglioma.
Literatur
1.
Zurück zum Zitat Isobe K, Nakai T, Yukimasa N, Nanmoku T, Takekoshi K and Nomura F (1998) Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas. Eur J Endocrinol 138:383–387.CrossRef Isobe K, Nakai T, Yukimasa N, Nanmoku T, Takekoshi K and Nomura F (1998) Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas. Eur J Endocrinol 138:383–387.CrossRef
2.
Zurück zum Zitat Osinga TE, Korpershoek E, de Krijger RR, Kerstens MN, Dullaart RPF, Kema IP, van der Laan BFAM, van der Horst-Schrivers ANA, Links TP (2015) Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue. Neuroendocrinology 101:289–295.CrossRef Osinga TE, Korpershoek E, de Krijger RR, Kerstens MN, Dullaart RPF, Kema IP, van der Laan BFAM, van der Horst-Schrivers ANA, Links TP (2015) Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue. Neuroendocrinology 101:289–295.CrossRef
3.
Zurück zum Zitat Meijer WG, Copray SC, Hollema H, Kema IP, Zwart N, Mantingh-Otter I, Links TP, Willemse PH, de Vries EG (2003) Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas. Clin Chem 49:586–593.CrossRef Meijer WG, Copray SC, Hollema H, Kema IP, Zwart N, Mantingh-Otter I, Links TP, Willemse PH, de Vries EG (2003) Catecholamine-synthesizing enzymes in carcinoid tumors and pheochromocytomas. Clin Chem 49:586–593.CrossRef
4.
Zurück zum Zitat Kimura N, Miura Y, Nagatsu I and Nagura H (1992) Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421:25–32.CrossRef Kimura N, Miura Y, Nagatsu I and Nagura H (1992) Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Arch A Pathol Anat Histopathol 421:25–32.CrossRef
5.
Zurück zum Zitat Kloeppel G, Lloyd R, Osamura R, Roasi J eds. (2017) Tumours of the adrenal medulla and extra-adrenal paraganglia. WHO Classification of Tumours of Endocrine Organs, 4th edn. Lyon: IARC Press; 179–195. Kloeppel G, Lloyd R, Osamura R, Roasi J eds. (2017) Tumours of the adrenal medulla and extra-adrenal paraganglia. WHO Classification of Tumours of Endocrine Organs, 4th edn. Lyon: IARC Press; 179–195.
6.
Zurück zum Zitat Goldstein RE, O'Neill JA, Jr., Holcomb GW, 3rd, et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755–764.CrossRef Goldstein RE, O'Neill JA, Jr., Holcomb GW, 3rd, et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755–764.CrossRef
7.
Zurück zum Zitat Edstrom Elder E, Hjelm Skog AL, Hoog A and Hamberger B (2003) The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol 29:278–283.CrossRef Edstrom Elder E, Hjelm Skog AL, Hoog A and Hamberger B (2003) The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol 29:278–283.CrossRef
8.
Zurück zum Zitat Lowery AJ, Walsh S, McDermott EW and Prichard RS (2013) Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist 18:391–407.CrossRef Lowery AJ, Walsh S, McDermott EW and Prichard RS (2013) Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist 18:391–407.CrossRef
9.
Zurück zum Zitat Tischler AS and deKrijger RR (2015) 15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma. Endocr Relat Cancer 22:T123–T133.CrossRef Tischler AS and deKrijger RR (2015) 15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma. Endocr Relat Cancer 22:T123–T133.CrossRef
10.
Zurück zum Zitat Strong VE, Kennedy T, Al-Ahmadie H, et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143:759–768.CrossRef Strong VE, Kennedy T, Al-Ahmadie H, et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143:759–768.CrossRef
11.
Zurück zum Zitat Thompson LD (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551–566.CrossRef Thompson LD (2002) Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551–566.CrossRef
12.
Zurück zum Zitat Wu D, Tischler AS, Lloyd RV, et al (2009) Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 33:99–608.CrossRef Wu D, Tischler AS, Lloyd RV, et al (2009) Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. Am J Surg Pathol 33:99–608.CrossRef
13.
Zurück zum Zitat Achilles E, Padberg BC, Holl K, Kloppel G and Schroder S (1991) Immunocytochemistry of paragangliomas—value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 18:453–458.CrossRef Achilles E, Padberg BC, Holl K, Kloppel G and Schroder S (1991) Immunocytochemistry of paragangliomas—value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology 18:453–458.CrossRef
14.
Zurück zum Zitat Tavangar SM, Shojaee A, Moradi Tabriz H, et al (2010) Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma. Pathol Res Pract 206:305–309.CrossRef Tavangar SM, Shojaee A, Moradi Tabriz H, et al (2010) Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma. Pathol Res Pract 206:305–309.CrossRef
15.
Zurück zum Zitat Tischler AS (2008) Pheochromocytoma: time to stamp out “malignancy”? Endocr Pathol 19:207–208.CrossRef Tischler AS (2008) Pheochromocytoma: time to stamp out “malignancy”? Endocr Pathol 19:207–208.CrossRef
16.
Zurück zum Zitat Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K (2006) High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 91:4505–4509.CrossRef Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K (2006) High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 91:4505–4509.CrossRef
17.
Zurück zum Zitat Feldman JM and Wells SA, Jr (1979) Adrenal-cortical function in patients with medullary carcinoma of the thyroid and pheochromocytoma. Horm Metab Res 11:567–570.CrossRef Feldman JM and Wells SA, Jr (1979) Adrenal-cortical function in patients with medullary carcinoma of the thyroid and pheochromocytoma. Horm Metab Res 11:567–570.CrossRef
18.
Zurück zum Zitat Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, Fonseca E, Ghillani PP, Aubert B, Travagli JP, Gardet P, Parmentier C (1992) Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15:631–642.CrossRef Schlumberger M, Gicquel C, Lumbroso J, Tenenbaum F, Comoy E, Bosq J, Fonseca E, Ghillani PP, Aubert B, Travagli JP, Gardet P, Parmentier C (1992) Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 15:631–642.CrossRef
19.
Zurück zum Zitat Huynh TT, Pacak K, Wong DL, et al (2006) Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Ann N Y Acad Sci 1073:241–252.CrossRef Huynh TT, Pacak K, Wong DL, et al (2006) Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Ann N Y Acad Sci 1073:241–252.CrossRef
20.
Zurück zum Zitat Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS Jr (1986) Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419–5425.PubMed Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS Jr (1986) Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419–5425.PubMed
21.
Zurück zum Zitat Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G and Plouin PF (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110–2116.CrossRef Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G and Plouin PF (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110–2116.CrossRef
22.
Zurück zum Zitat Feng F, Zhu Y, Wang X, Wu YX, Zhou WL, Jin XL, Zhang RM, Sun FK, Kasoma Z, Shen ZJ (2011) Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J Urol 185:1583–1590.CrossRef Feng F, Zhu Y, Wang X, Wu YX, Zhou WL, Jin XL, Zhang RM, Sun FK, Kasoma Z, Shen ZJ (2011) Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J Urol 185:1583–1590.CrossRef
23.
Zurück zum Zitat Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giachè V, Mannelli M. (2012) Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. J Oncol. 2012: 872713.CrossRef Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giachè V, Mannelli M. (2012) Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. J Oncol. 2012: 872713.CrossRef
24.
Zurück zum Zitat Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M (2014) Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 21:L13–L16.CrossRef Kimura N, Takekoshi K, Horii A, Morimoto R, Imai T, Oki Y, Saito T, Midorikawa S, Arao T, Sugisawa C, Yamada M, Otuka Y, Kurihara I, Sugano K, Nakane M, Fukuuchi A, Kitamoto T, Saito J, Nishikawa T, Naruse M (2014) Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 21:L13–L16.CrossRef
25.
Zurück zum Zitat Koh JM, Ahn SH, Kim H, et al. (2017) Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS One 12(11):e0187398.CrossRef Koh JM, Ahn SH, Kim H, et al. (2017) Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS One 12(11):e0187398.CrossRef
26.
Zurück zum Zitat Foo SH, Chan SP, Ananda V and Rajasingam V (2010) Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management. Singapore Med J 51:e89–e93.PubMed Foo SH, Chan SP, Ananda V and Rajasingam V (2010) Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management. Singapore Med J 51:e89–e93.PubMed
27.
Zurück zum Zitat Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P (1986) Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162.PubMed Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P (1986) Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162.PubMed
28.
Zurück zum Zitat Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K (2005) Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075.CrossRef Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K (2005) Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075.CrossRef
29.
Zurück zum Zitat Brown MJ and Dollery CT (1981) A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol 11(1):79–83.CrossRef Brown MJ and Dollery CT (1981) A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol 11(1):79–83.CrossRef
30.
Zurück zum Zitat Kang UJ, Park DH, Wessel T, Baker H and Joh TH (1992) Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci Lett 147:53–57.CrossRef Kang UJ, Park DH, Wessel T, Baker H and Joh TH (1992) Dopa-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci Lett 147:53–57.CrossRef
31.
Zurück zum Zitat Li XM, Qi J, Juorio AV and Boulton AA (1997) Reciprocal regulation of the content of aromatic L-amino acid decarboxylase and tyrosine hydroxylase mRNA by NGF in PC12 cells. J Neurosci Res 47:449–454.CrossRef Li XM, Qi J, Juorio AV and Boulton AA (1997) Reciprocal regulation of the content of aromatic L-amino acid decarboxylase and tyrosine hydroxylase mRNA by NGF in PC12 cells. J Neurosci Res 47:449–454.CrossRef
32.
Zurück zum Zitat Levi-Montalcini R and Angeletti PU (1968) Nerve growth factor. Physiol Rev 48:534–569.CrossRef Levi-Montalcini R and Angeletti PU (1968) Nerve growth factor. Physiol Rev 48:534–569.CrossRef
33.
Zurück zum Zitat Herrup K and Thoenen H (1979) Properties of the nerve growth factor receptor of a clonal line of rat pheochromocytoma (PC12) cells. Exp Cell Res 121:71–78.CrossRef Herrup K and Thoenen H (1979) Properties of the nerve growth factor receptor of a clonal line of rat pheochromocytoma (PC12) cells. Exp Cell Res 121:71–78.CrossRef
34.
Zurück zum Zitat Landreth GE and Shooter EM (1980) Nerve growth factor receptors on PC12 cells: ligand-induced conversion from low- to high-affinity states. Proc Natl Acad Sci U S A 77:4751–4755.CrossRef Landreth GE and Shooter EM (1980) Nerve growth factor receptors on PC12 cells: ligand-induced conversion from low- to high-affinity states. Proc Natl Acad Sci U S A 77:4751–4755.CrossRef
35.
Zurück zum Zitat Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC and Zielke A (2002) In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Exp Clin Endocrinol Diabetes 110:386–392.CrossRef Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC and Zielke A (2002) In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Exp Clin Endocrinol Diabetes 110:386–392.CrossRef
36.
Zurück zum Zitat Favier J, Plouin P-F, Corvol P and Gasc J-M (2002) Angiogenesis and Vascular Architecture in Pheochromocytomas. Am J Pathol 161:1235–1246.CrossRef Favier J, Plouin P-F, Corvol P and Gasc J-M (2002) Angiogenesis and Vascular Architecture in Pheochromocytomas. Am J Pathol 161:1235–1246.CrossRef
Metadaten
Titel
Catecholamine-Synthesizing Enzymes in Pheochromocytoma and Extraadrenal Paraganglioma
verfasst von
Sachiko Konosu-Fukaya
Kei Omata
Yuta Tezuka
Yoshikiyo Ono
Yayoi Aoyama
Fumitoshi Satoh
Fumiyoshi Fujishima
Hironobu Sasano
Yasuhiro Nakamura
Publikationsdatum
28.08.2018
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2018
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-018-9544-5

Weitere Artikel der Ausgabe 4/2018

Endocrine Pathology 4/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …